Glucagon-Like Peptide-1 Receptor Agonist Prevented the Progression of Hepatocellular Carcinoma in a Mouse Model of Nonalcoholic Steatohepatitis

Glucagon-like peptide-1 (GLP-1) receptor agonists are used to treat diabetes, but their effects on nonalcoholic steatohepatitis (NASH) and the development of hepatocellular carcinoma (HCC) remain unclear. In this study, mice with streptozotocin- and high-fat diet-induced diabetes and NASH were subcu...

Descripción completa

Detalles Bibliográficos
Autores principales: Kojima, Motoyasu, Takahashi, Hirokazu, Kuwashiro, Takuya, Tanaka, Kenichi, Mori, Hitoe, Ozaki, Iwata, Kitajima, Yoichiro, Matsuda, Yayoi, Ashida, Kenji, Eguchi, Yuichiro, Anzai, Keizo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460814/
https://www.ncbi.nlm.nih.gov/pubmed/32785012
http://dx.doi.org/10.3390/ijms21165722

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460814/
https://www.ncbi.nlm.nih.gov/pubmed/32785012
http://dx.doi.org/10.3390/ijms21165722

Ejemplares similares